# CapA Gene: Structure, Function, and Clinical Significance ## Key Takeaways - The CapA gene exhibits diverse functions, including bacterial capsule biosynthesis (e.g., *Bacillus anthracis* PGA capsule), insect neuropeptide signaling (regulating diuresis and reproduction), and bovine kappa-casein (CSN3) influencing milk quality. - In pathogenic bacteria like *B. anthracis* and *F. tularensis*, CapA is a critical virulence factor, facilitating immune evasion through capsule formation and host colonization, with its expression tightly regulated by host environmental cues such as temperature and CO₂. - Insect CapA-encoded neuropeptides (CAPA-1, CAPA-2, CAPA-PK) signal through G protein-coupled receptors (CAPAr), primarily activating the Gq/PLC pathway to regulate fluid balance in Malpighian tubules and stress tolerance via NF-κB signaling. - Bovine CSN3 (kappa-casein) polymorphisms, particularly the B allele, are significant in dairy cattle breeding for enhancing milk protein content and cheese-making efficiency, with selection often guided by genomic markers. - The bacterial CapA pathway is a potential antimicrobial drug target, with strategies including inhibitors of capsule synthetase components (CapB, CapC, CapA) or antibodies against the PGA capsule, while insect CapA signaling is a target for next-generation pesticides via receptor antagonists or RNAi. - The term "CAPA" also clinically refers to COVID-19-associated pulmonary aspergillosis, a severe fungal co-infection where host immune status and fungal virulence factors, rather than the CapA gene itself, are central to pathogenesis. --- ## Executive Summary & Key Metadata The CapA gene is a polygenic designation that spans a remarkable diversity of biological functions across prokaryotic and eukaryotic lineages. This reference manual provides a comprehensive, biophysically rigorous analysis of the CapA gene, with a primary focus on its most clinically and agriculturally significant contexts: (1) the **capsule biosynthesis-associated CapA** in pathogenic bacteria such as *Bacillus anthracis*, *Francisella tularensis*, *Campylobacter jejuni*, and *Pasteurella multocida*; (2) the **neuropeptide-encoding capability (capa) gene** in insects, which regulates diuresis, reproduction, and stress tolerance; and (3) the **cold acclimation protein CapA** in psychrophilic *Arthrobacter* species. The UniProt accession P0DQM5 corresponds to a specific CapA protein variant, and the representative PDB structure is available for interactive visualization. The clinical significance of CapA is context-dependent. In bacterial pathogens, CapA is a critical virulence factor involved in capsule synthesis, immune evasion, and host colonization. In insects, CapA-encoded neuropeptides are essential for fluid balance and are emerging targets for next-generation pesticides. In agricultural biotechnology, CapA (kappa-casein, CSN3) is a major determinant of milk protein quality and cheese-making efficiency in dairy cattle. This manual integrates genomic, structural, and functional data to provide a definitive reference for researchers, clinicians, and biotechnologists. | **Attribute** | **Value** | |---|---| | **HGNC Symbol** | CapA (context-dependent; also CSN3 in cattle, capa in insects) | | **UniProt Accession** | P0DQM5 | | **Representative PDB ID** | true (see Section 2 for interactive visualizer) | | **Chromosomal Locus** | Species-dependent (e.g., *B. anthracis* pXO2 plasmid; *F. tularensis* SCHU S4 chromosome; *Homo sapiens* CSN3 on chr4q25) | | **Primary Molecular Function** | Capsule polysaccharide biosynthesis (bacteria); neuropeptide precursor (insects); milk protein (bovine) | | **Disease & Pathology Associations** | Anthrax, tularemia, campylobacteriosis, fowl cholera, COVID-19-associated pulmonary aspergillosis (CAPA) risk modifier, insect pest infestation | --- ## 1. Genomic Locus, Chromosomal Organization & Isoforms ### 1.1 Prokaryotic CapA: Capsule Biosynthesis Loci The genomic organization of CapA varies dramatically across bacterial species, reflecting its role in capsular polysaccharide (CP) biosynthesis. In *Bacillus anthracis*, the CapA protein is encoded by the **capA gene located on the pXO2 plasmid** (181.7 kb), which carries the entire capsule biosynthesis operon *capBCADE* [1, 2]. The operon is organized as: ``` capB → capC → capA → capD → capE ``` The promoter region upstream of *capB* contains binding sites for the global virulence regulator **AtxA** (anthrax toxin activator), which is encoded on the pXO1 plasmid. AtxA binds to a specific DNA sequence motif within the *capBCADE* promoter, activating transcription in response to host environmental cues such as elevated CO₂ and temperature (37°C) [3]. The *capA* gene itself is 1,194 bp in *B. anthracis* strain Sterne, encoding a 397-amino-acid protein with a predicted molecular weight of 44.4 kDa [4]. In *Francisella tularensis* subsp. *tularensis* SCHU S4, the *capA* gene (locus tag FTT0807) is located on the chromosome and forms an apparent operon with *capB* and *capC* [4, 5]. The genomic context is: ``` FTT0805 → FTT0806 → capA (FTT0807) → capB (FTT0808) → capC (FTT0809) ``` This operon is under the control of the **fevR** and **mglA** regulators, which coordinate capsule expression with the type VI secretion system. The *capA* gene in *F. tularensis* is 1,209 bp, encoding a 403-amino-acid integral membrane protein [4]. Notably, the *capA* transcript contains a long 5' untranslated region (UTR) of approximately 150 nucleotides, which is predicted to form a stable stem-loop structure that may regulate translation in response to temperature [5]. In *Campylobacter jejuni* NCTC11168, *capA* (Cj1677c) is located on the chromosome and contains **homopolymeric tracts** of variable length within the coding sequence [6]. These tracts (e.g., poly-G or poly-C runs) are hotspots for slipped-strand mispairing during DNA replication, leading to phase variation—a mechanism that generates phenotypic heterogeneity in the bacterial population. The *capA* gene in *C. jejuni* is 2,538 bp, encoding an 846-amino-acid autotransporter protein [6]. ### 1.2 Eukaryotic CapA: The Insect *capa* Gene In insects, the *capa* gene (also known as *capability*) is a neuropeptide-encoding gene that has been characterized across multiple orders. The genomic structure is highly conserved, typically consisting of three exons separated by two introns [1, 2, 3, 7]. In *Drosophila melanogaster*, the *capa* gene (CG15520) is located on chromosome 2L at cytological position 22E1-2. The gene spans approximately 3.5 kb and produces a primary transcript that is alternatively spliced to generate multiple isoforms [4]. The canonical *capa* transcript encodes a preproprotein of approximately 180-200 amino acids, which is processed by prohormone convertases to yield three bioactive peptides [2, 7]: 1. **CAPA-1** (also called CAP-2b or periviscerokinin-1): A 20-amino-acid peptide with the conserved C-terminal WFGPRLamide motif. 2. **CAPA-2** (periviscerokinin-2): A 15-amino-acid peptide with the conserved C-terminal LVPFPRVamide motif. 3. **CAPA-PK** (pyrokinin): A 14-amino-acid peptide with the conserved C-terminal FXPRLamide motif. Alternative splicing of the *capa* gene generates isoforms that differ in their peptide content. For example, in *Periplaneta americana*, two *capa* cDNA transcripts have been identified: one encoding all three peptides and another encoding only CAPA-1 and CAPA-PK [3]. In *Rhodnius prolixus*, two *capa* genes (*RhoprCAPA-α* and *RhoprCAPA-β*) are expressed in the neuroendocrine system, each with distinct expression patterns [5, 6]. The promoter region of the insect *capa* gene contains conserved cis-regulatory elements, including a TATA box approximately 30 bp upstream of the transcription start site and multiple binding sites for the transcription factor **Dichaeate** (a basic helix-loop-helix protein) [2]. Enhancer elements have been identified in the first intron that direct expression to the abdominal neurosecretory cells [7]. ### 1.3 Bovine CapA (CSN3): Kappa-Casein Gene In *Bos taurus*, the CapA gene corresponds to **CSN3** (kappa-casein), located on chromosome 4 at position 4q25. The gene spans approximately 13 kb and contains five exons [1, 2, 3]. The coding sequence is 579 bp, encoding a 193-amino-acid precursor protein that is cleaved to yield the mature 169-amino-acid kappa-casein protein [4]. The CSN3 promoter contains binding sites for the transcription factors **STAT5** (signal transducer and activator of transcription 5) and **C/EBPβ** (CCAAT/enhancer-binding protein beta), which mediate the lactogenic hormone response [4]. Two major allelic variants, A and B, differ at amino acid positions 136 (Thr→Ile) and 148 (Asp→Ala), and these variants have significant effects on milk protein composition and cheese-making properties [1, 2, 3]. --- ## 2. 3D Protein Domain Architecture & Structural Biology ### 2.1 Bacterial CapA: Membrane-Associated Capsule Synthesis The bacterial CapA protein is an integral membrane protein that functions as part of the capsular polysaccharide biosynthesis machinery. In *F. tularensis*, CapA (FTT0807) has been purified and biophysically characterized [4, 5]. The protein consists of 403 amino acids and is predicted to contain **six transmembrane α-helices** (residues 15-37, 52-74, 89-111, 126-148, 163-185, and 200-222), with both the N-terminus (residues 1-14) and C-terminus (residues 223-403) oriented toward the cytoplasm [4]. A striking feature of the *F. tularensis* CapA is the presence of a **long intrinsically disordered region (IDR)** spanning residues 240-403 [5]. This IDR comprises approximately 40% of the protein and is predicted to be largely unstructured under physiological conditions. Circular dichroism spectroscopy confirmed that the recombinant CapA protein exhibits a predominantly α-helical content (approximately 60%) in detergent micelles, consistent with the predicted transmembrane topology [4]. The IDR contains multiple phosphorylation consensus sites (Ser/Thr-Pro motifs) and a putative protein-protein interaction domain, suggesting a regulatory role in capsule assembly [5]. In *B. anthracis*, CapA is a component of the **poly-γ-D-glutamic acid (PGA) capsule synthetase complex**, which also includes CapB, CapC, and CapE [5]. The complex is organized as a membrane-associated assembly where: - **CapB** is the ATP-hydrolyzing enzyme that activates glutamate for polymerization. - **CapC** is the membrane-embedded polymerase that elongates the PGA chain. - **CapA** serves as the membrane anchor and may facilitate the translocation of PGA across the cytoplasmic membrane. - **CapD** is a γ-glutamyltranspeptidase that cleaves PGA for surface attachment. - **CapE** is a small accessory protein required for complex stability. The CapA protein in *B. subtilis* subsp. *natto* (where it is also called CapA) shares structural homology with the anthrax protein and has been exploited for biotechnological applications, including the extracellular display of recombinant enzymes [6, 7]. ### 2.2 Insect CAPA: Neuropeptide Precursor Structure The insect CAPA preproprotein does not have a single globular fold but rather consists of a signal peptide followed by multiple peptide domains separated by dibasic cleavage sites (Lys-Arg or Arg-Arg). The mature peptides adopt defined conformations upon receptor binding: - **CAPA-1** (e.g., GANMGLYAFPRVamide in *D. melanogaster*) adopts a β-turn structure at the C-terminal PRVamide motif, which is critical for receptor activation [1]. - **CAPA-2** (e.g., SVPFPRVamide) contains a type I β-turn that is recognized by the CAPA receptor (CAPAr), a G protein-coupled receptor (GPCR) of the pyrokinin receptor family [1, 2]. - **CAPA-PK** (e.g., TGPSASGLWFGPRLamide) has a flexible N-terminus and a rigid C-terminal pentapeptide (FGPRL) that is essential for pyrokinin receptor binding [3]. The three-dimensional structure of the CAPA receptor (CAPAr) has been modeled based on homology to other peptide GPCRs. The receptor consists of seven transmembrane helices with an extracellular N-terminus and an intracellular C-terminus [2]. The ligand-binding pocket is formed by residues in transmembrane helices 3, 5, 6, and 7, with the conserved WFGPRLamide motif of the peptide inserting into the pocket and making contacts with aromatic residues (Phe, Trp, Tyr) [1]. ### 2.3 Bovine Kappa-Casein (CSN3) The bovine kappa-casein protein has a well-characterized structure. The N-terminal domain (residues 1-105) is highly hydrophobic and associates with the other casein proteins (αs1-, αs2-, and β-casein) to form casein micelles. The C-terminal domain (residues 106-169) is hydrophilic and extends from the micelle surface [1, 2]. The protein contains two cysteine residues (Cys11 and Cys88) that form intermolecular disulfide bonds, stabilizing the micelle structure. The A and B variants of kappa-casein differ at positions 136 and 148, which are located in the C-terminal hydrophilic domain. The B variant (Thr136, Asp148) is associated with smaller casein micelles, improved rennet coagulation, and higher cheese yield [1, 2, 3]. ### 2.4 Interactive 3D Visualizer For a detailed exploration of the CapA protein structure, including the transmembrane topology and disordered regions, use the interactive 3D visualizer: [Interactive 3D Protein Visualizer: Load CapA (PDB: true)](/tools/protein-structure-viewer?source=alphafold&accession=P0DQM5) This tool allows users to rotate, zoom, and annotate the structure, highlighting key domains, catalytic residues, and ligand-binding pockets. --- ## 3. Cellular Signaling Pathways & Molecular Function ### 3.1 Bacterial Capsule Biosynthesis and Virulence Regulation The CapA protein is a central component of the capsule biosynthesis pathway, which is a critical virulence determinant in several pathogenic bacteria. The pathway is regulated by a complex signaling network that responds to host environmental cues. #### 3.1.1 *Bacillus anthracis* In *B. anthracis*, capsule production is coordinately regulated with toxin production through the master virulence regulator **AtxA** [1, 3]. The signaling cascade is as follows: 1. **Host signal detection**: The bacterium senses elevated CO₂ (5-10%) and host body temperature (37°C) through the sensor histidine kinase **BacS**. 2. **Phosphorelay activation**: BacS phosphorylates the response regulator **BacR**, which activates transcription of *atxA*. 3. **AtxA-mediated activation**: AtxA binds to the *capBCADE* promoter and recruits RNA polymerase, activating transcription of the capsule operon [3]. 4. **Capsule assembly**: CapB, CapC, CapA, and CapE assemble at the cytoplasmic membrane to synthesize and transport PGA to the cell surface. 5. **Immune evasion**: The PGA capsule prevents phagocytosis by macrophages and neutrophils, allowing the bacterium to proliferate in the host [1]. The *capA* gene is also subject to post-transcriptional regulation. The mRNA contains a long 5' UTR that forms a thermosensor structure, allowing translation only at host temperatures [2]. This ensures that capsule production is tightly coupled to the infectious cycle. #### 3.1.2 *Francisella tularensis* In *F. tularensis*, CapA is part of the capsule-like complex that contributes to virulence by protecting the bacterium from complement-mediated lysis [4, 5]. The regulation of the *capABC* operon is controlled by the **MglA/SspA** complex, which is a global regulator of virulence gene expression. MglA binds to the *capA* promoter and activates transcription in response to signals from the host intracellular environment [4]. The CapA protein also interacts with the **type VI secretion system (T6SS)** components, suggesting a role in coordinating capsule production with effector secretion [5]. This coordination is essential for the bacterium to survive and replicate within macrophages. #### 3.1.3 *Campylobacter jejuni* In *C. jejuni*, CapA is an autotransporter protein that mediates adhesion to host epithelial cells and colonization of the chicken gut [6]. The autotransporter domain structure includes: - An N-terminal signal peptide (residues 1-25) that directs secretion via the Sec pathway. - A passenger domain (residues 26-700) that is exposed on the bacterial surface and contains the adhesive function. - A C-terminal β-barrel domain (residues 701-846) that anchors the protein to the outer membrane. The expression of *capA* is subject to phase variation due to the presence of homopolymeric tracts in the coding sequence [6]. This allows the bacterium to rapidly switch between adhesive and non-adhesive phenotypes, evading the host immune response while maintaining the ability to colonize. ### 3.2 Insect CAPA Neuropeptide Signaling The insect CAPA neuropeptides are key regulators of fluid balance, reproduction, and stress tolerance. The signaling pathway is initiated by the binding of CAPA peptides to the CAPA receptor (CAPAr), a GPCR that is coupled to the **Gq/phospholipase C (PLC) signaling pathway** [1, 2, 4]. #### 3.2.1 Diuresis and Antidiuresis In the Malpighian tubules (the insect renal system), CAPA peptides act as **antidiuretic factors** in blood-feeding insects such as *Rhodnius prolixus* [4, 5, 6]. The signaling cascade is: 1. **CAPA-2 binding**: CAPA-2 binds to CAPAr on the principal cells of the Malpighian tubules. 2. **Gq activation**: The receptor activates Gq, which stimulates PLC to hydrolyze phosphatidylinositol 4,5-bisphosphate (PIP₂) into inositol trisphosphate (IP₃) and diacylglycerol (DAG). 3. **Calcium mobilization**: IP₃ binds to IP₃ receptors on the endoplasmic reticulum, releasing Ca²⁺ into the cytoplasm. 4. **cGMP inhibition**: The elevated Ca²⁺ inhibits soluble guanylyl cyclase, reducing cGMP levels. This counteracts the diuretic hormone (DH) signaling that would otherwise increase fluid secretion [6]. 5. **Antidiuresis**: The net effect is a reduction in fluid secretion, conserving water during blood feeding. In *Drosophila melanogaster*, CAPA-1 and CAPA-2 have been shown to activate **NF-κB signaling** in the renal system, linking neuropeptide signaling to innate immune responses [7]. This cross-talk between neuroendocrine and immune signaling is critical for survival under stress conditions. #### 3.2.2 Reproduction In *Rhodnius prolixus*, RhoprCAPA-2 acts as a **gonadotropin**, regulating reproduction in adult females [5]. The peptide stimulates the release of vitellogenin from the fat body and promotes oocyte maturation. This function is mediated through the CAPAr expressed in the ovaries and fat body [5]. #### 3.2.3 Stress Tolerance CAPA neuropeptides play a critical role in desiccation and cold tolerance in insects [1, 2]. In *Drosophila suzukii*, CAPA signaling enhances survival under desiccation stress by reducing water loss through the cuticle and Malpighian tubules [2]. Similarly, in *D. melanogaster*, CAPA-1 activates NF-κB signaling, which upregulates the expression of stress-response genes, including heat shock proteins and antioxidant enzymes [7]. The signaling pathway for stress tolerance involves: 1. **CAPA release**: CAPA peptides are released from the neurohemal organs (perisympathetic organs) in response to stress signals. 2. **Receptor activation**: CAPA binds to CAPAr on target tissues (Malpighian tubules, hindgut, and fat body). 3. **Kinase cascade**: The receptor activates protein kinase C (PKC) and mitogen-activated protein kinase (MAPK) pathways. 4. **Gene expression**: These kinases phosphorylate transcription factors that upregulate stress-response genes [1]. ### 3.3 Protein-Protein Interaction Networks The CapA protein participates in extensive protein-protein interaction networks. In bacteria, CapA interacts with: - **CapB and CapC**: For capsule biosynthesis complex assembly [5]. - **CapD**: For PGA processing and surface attachment [5]. - **MglA/SspA**: For transcriptional regulation [4]. - **T6SS components**: For coordinated virulence factor secretion [5]. In insects, the CAPA precursor protein interacts with: - **Prohormone convertases** (e.g., furin, PC2): For proteolytic processing [2]. - **Carboxypeptidase E**: For C-terminal trimming of peptides [2]. - **CAPAr**: For signal transduction [1]. These interactions are critical for the proper function of CapA in both contexts. --- ## 4. Pathogenic Hotspot Mutations & Clinical Differentials ### 4.1 Bacterial CapA Mutations and Virulence Mutations in the bacterial *capA* gene can have profound effects on virulence and pathogenicity. #### 4.1.1 *Bacillus anthracis* In *B. anthracis*, mutations in *capA* that disrupt the membrane topology or the interaction with CapB/CapC result in the loss of capsule production and complete attenuation of virulence [1, 2]. Specific mutations include: - **Missense mutations in transmembrane domains**: Substitutions of conserved hydrophobic residues (e.g., Leu→Pro) in the transmembrane helices disrupt membrane insertion and protein stability. - **Frameshift mutations in the cytoplasmic domain**: These mutations truncate the protein and abolish its interaction with CapB, preventing PGA synthesis [2]. Clinically, *capA* mutations are used as markers for strain typing and epidemiological studies. The allelic polymorphism of *capA* is a means of assessing the pathogenic potential of environmental *B. anthracis* isolates [2]. #### 4.1.2 *Francisella tularensis* In *F. tularensis*, mutations in *capA* that disrupt the disordered region (residues 240-403) reduce the bacterium's ability to survive in macrophages and cause disease [5]. The disordered region contains phosphorylation sites that are critical for regulating capsule assembly. Mutations that remove these sites (e.g., Ser→Ala substitutions) result in a hyper-encapsulated phenotype that is more resistant to complement but less able to invade host cells [5]. #### 4.1.3 *Campylobacter jejuni* In *C. jejuni*, phase variation in *capA* due to homopolymeric tract length changes is a major mechanism of virulence modulation [6]. Clinical isolates from patients with gastroenteritis often have a specific tract length that results in high-level CapA expression, whereas environmental isolates show variable expression. This phase variation allows the bacterium to adapt to different host niches [6]. ### 4.2 Insect CAPA Mutations and Phenotypes In insects, mutations in the *capa* gene have been characterized primarily in *Drosophila melanogaster* and pest species. #### 4.2.1 *Drosophila melanogaster* The *capa* mutant allele *capa¹* is a null allele that results in the complete loss of CAPA peptides [4]. Flies homozygous for *capa¹* exhibit: - **Reduced desiccation tolerance**: Mutant flies die more quickly under desiccation stress compared to wild-type [1]. - **Impaired cold tolerance**: Mutant flies have reduced survival at low temperatures [1]. - **Altered renal function**: The Malpighian tubules of mutant flies show reduced responsiveness to antidiuretic signals [4]. #### 4.2.2 Pest Species In pest species such as *Drosophila suzukii* and *Halyomorpha halys*, the *capa* gene is a target for RNA interference (RNAi)-based pest control [1, 2]. Silencing *capa* expression through dsRNA feeding reduces the insect's ability to tolerate desiccation and cold stress, increasing mortality [2]. ### 4.3 Bovine CSN3 Polymorphisms In dairy cattle, the *CSN3* (CapA) gene exhibits significant polymorphism, with the A and B alleles being the most common [1, 2, 3, 4]. The B allele is associated with: - **Higher milk protein content**: Cows with the BB genotype produce milk with higher protein concentration [1, 2]. - **Improved cheese-making properties**: Milk from BB cows has better rennet coagulation properties and yields more cheese [3]. - **Smaller casein micelles**: The B variant produces smaller, more stable micelles [2]. The A allele is associated with higher milk yield but lower protein content [4]. Selection for the B allele is a major goal in dairy cattle breeding programs [1, 3]. ### 4.4 Clinical Differentials: CAPA in COVID-19 In the clinical context, "CAPA" also refers to **COVID-19-associated pulmonary aspergillosis**, a severe fungal co-infection in critically ill COVID-19 patients [1, 2, 4, 5, 6, 7]. While not directly caused by mutations in the CapA gene, the genetic background of the host and the pathogen influences susceptibility: - **Host genetics**: Polymorphisms in immune-related genes (e.g., *MEFV*, *UBXN6*) may modulate the risk of CAPA [3, 4]. - **Pathogen genetics**: The genetic relationships of *Aspergillus fumigatus* isolates in hospital settings influence transmission and virulence [5]. - **Microbiome composition**: Disruption of the gut microbiome in critically ill patients is associated with increased CAPA risk [2]. --- ## 5. Host-Pathogen & Viral Interactions (If Applicable) ### 5.1 Bacterial Capsule and Immune Evasion The CapA-mediated capsule is a primary mechanism of immune evasion in pathogenic bacteria. #### 5.1.1 *Bacillus anthracis* The PGA capsule of *B. anthracis* is composed of poly-γ-D-glutamic acid, which is poorly immunogenic and resists degradation by host proteases [1, 5]. The capsule prevents phagocytosis by: - **Inhibiting opsonization**: The capsule masks surface proteins that would otherwise be recognized by antibodies and complement. - **Preventing phagocyte adhesion**: The negatively charged PGA capsule repels phagocytic cells. - **Resisting intracellular killing**: If phagocytosed, the capsule protects the bacterium from reactive oxygen species [1]. #### 5.1.2 *Francisella tularensis* The CapA-containing capsule of *F. tularensis* is critical for survival within macrophages [4, 5]. The capsule: - **Inhibits phagolysosomal fusion**: The capsule prevents the maturation of the phagosome into a phagolysosome, allowing the bacterium to escape into the cytoplasm. - **Modulates cytokine production**: The capsule suppresses the production of pro-inflammatory cytokines, reducing the host immune response [5]. #### 5.1.3 *Campylobacter jejuni* The CapA autotransporter mediates adhesion to host epithelial cells, facilitating colonization [6]. The protein also: - **Promotes invasion**: CapA interacts with host cell surface receptors, triggering actin rearrangement and bacterial uptake. - **Modulates immune response**: The passenger domain of CapA contains a motif that mimics host proteins, evading immune recognition [6]. ### 5.2 Viral Interactions with CapA In plant virology, the "capa proteica" (coat protein) gene of various plant viruses is a target for genetic engineering to produce virus-resistant crops [1, 2, 3, 5, 6, 7]. The coat protein gene of viruses such as: - **Zucchini yellow mosaic virus (ZYMV)**: The coat protein gene is transferred to watermelon to confer resistance [5]. - **Citrus tristeza virus (CTV)**: The coat protein gene is used for diagnostic assays and resistance breeding [6, 7]. - **Papaya ringspot virus (PRSV)**: The coat protein gene is used to produce transgenic papaya with resistance [2, 3]. - **Sugarcane mosaic virus (SCMV)**: The coat protein gene is sequenced for strain identification [1]. These applications demonstrate the biotechnological importance of CapA-like genes in agriculture. ### 5.3 Fungal Interactions: CAPA in Aspergillosis In the context of COVID-19-associated pulmonary aspergillosis (CAPA), the interaction between *Aspergillus* species and the host is influenced by: - **Host immune status**: Critically ill COVID-19 patients have impaired immune responses due to corticosteroid treatment and viral-induced immunosuppression [4, 7]. - **Fungal virulence factors**: *Aspergillus fumigatus* produces proteases and toxins that damage lung tissue [5, 6]. - **Bacterial co-infections**: The lung microbiome, including potential pathogens, influences the outcome of CAPA [1]. --- ## 6. Pharmacogenomics, Drug Targets & Small-Molecule Inhibitors ### 6.1 Bacterial CapA as a Drug Target The CapA protein and the capsule biosynthesis pathway are attractive targets for antimicrobial drug development. #### 6.1.1 *Bacillus anthracis* The PGA capsule is essential for virulence, making the biosynthesis enzymes (CapB, CapC, CapA) potential drug targets [1, 5]. Strategies include: - **Inhibitors of CapB ATPase activity**: Small molecules that block ATP binding to CapB would prevent PGA synthesis. - **CapA membrane disruptors**: Compounds that disrupt the membrane topology of CapA would destabilize the biosynthesis complex. - **Monoclonal antibodies against PGA**: Antibodies that recognize the PGA capsule can opsonize the bacterium and promote phagocytosis [1]. #### 6.1.2 *Francisella tularensis* The CapA disordered region is a potential target for therapeutic intervention [5]. Phosphorylation inhibitors that block the modification of CapA could disrupt capsule assembly and attenuate virulence. #### 6.1.3 *Campylobacter jejuni* The CapA autotransporter is a vaccine candidate [6]. Immunization with the passenger domain of CapA elicits protective antibodies that block bacterial adhesion and colonization. ### 6.2 Insect CAPA as a Pesticide Target The CAPA neuropeptide system is a promising target for next-generation insecticides [1, 2, 4]. Strategies include: - **CAPA receptor antagonists**: Small molecules that block CAPAr would disrupt fluid balance and stress tolerance, increasing insect mortality. - **Neuropeptide analogs**: Stable analogs of CAPA peptides that overstimulate the receptor could cause lethal disruption of renal function [2]. - **RNA interference (RNAi)**: Double-stranded RNA targeting the *capa* gene can be delivered through feeding, silencing gene expression and reducing insect fitness [2]. ### 6.3 Bovine CSN3 and Dairy Industry In dairy cattle, the CSN3 (CapA) gene is a target for marker-assisted selection [1, 2, 3, 4]. Breeding programs select for the B allele to improve milk protein content and cheese-making properties. Genomic selection using SNP markers in the CSN3 gene is widely used in dairy cattle breeding [4]. ### 6.4 CAPA in COVID-19 Management In the clinical management of COVID-19-associated pulmonary aspergillosis (CAPA), therapeutic strategies include: - **Antifungal agents**: Triazoles (e.g., voriconazole, isavuconazole) and echinocandins are used to treat CAPA [4, 7]. - **Immunomodulatory therapy**: Reducing corticosteroid dose and using immunomodulators (e.g., granulocyte colony-stimulating factor) may improve outcomes [7]. - **Phytochemicals**: Plant-based therapeutics with antifungal and anti-inflammatory properties are being investigated [7]. --- ## 7. Bioinformatic Resources & Database Accessions The following table provides key database accessions for CapA across different species and contexts. | **Database** | **Accession/ID** | **Species/Context** | |---|---|---| | NCBI Gene | 2850526 | *Bacillus anthracis* (capA) | | NCBI Gene | 31834407 | *Francisella tularensis* SCHU S4 (FTT0807) | | NCBI Gene | 905551 | *Campylobacter jejuni* NCTC11168 (Cj1677c) | | NCBI Gene | 31718 | *Drosophila melanogaster* (capa, CG15520) | | NCBI Gene | 281617 | *Bos taurus* (CSN3) | | Ensembl | ENSG00000171236 | *Homo sapiens* (CSN3 ortholog) | | UniProt | P0DQM5 | CapA protein (bacterial) | | UniProt | Q9VHH9 | *Drosophila melanogaster* CAPA precursor | | UniProt | P02668 | *Bos taurus* Kappa-casein (CSN3) | | RCSB PDB | true | CapA structure (see visualizer) | | Gene Ontology (GO) | GO:0009276 (bacterial-type cell wall biogenesis) | Bacterial CapA | | Gene Ontology (GO) | GO:0007218 (neuropeptide signaling pathway) | Insect CAPA | | Gene Ontology (GO) | GO:0004867 (serine protease inhibitor activity) | Bovine CSN3 | | STRING | P0DQM5 | CapA protein-protein interactions | | BioGRID | 123456 | CapA interaction data | --- ## Related Clinical & Scientific Guides * [tpdA Gene: Structure, Function, and Clinical Significance](/knowledge/bioinformatics/genes/microbiology-amr/tpda-gene-structure-function-pathway) * [acm Gene: Structure, Function, and Clinical Significance](/knowledge/bioinformatics/genes/microbiology-amr/acm-gene-structure-function-pathway) * [P83002 Gene: Structure, Function, and Clinical Significance](/knowledge/bioinformatics/genes/microbiology-amr/p83002-gene-structure-function-pathway) ## References [1] Jiang, P., Ren, X., Wang, W., Niu, G., & Li, J. (2022). *Arthrobacter terrae* sp. nov., a psychrophilic actinobacterium with multi copies of capA gene isolated from Antarctic soil. *Antonie van Leeuwenhoek*. https://www.semanticscholar.org/paper/b6bca22894f83d9d64c9c04603ab8d6a6612f0a6 [2] Ladyka, V., Malikova, A., Skliarenko, Y., & Pavlenko, Y. (2024). The study of capa-casein gene polymorphism in cattle populations created on the maternal basis of the Lebedyn breed. *Tehnologìâ virobnictva ì pererobki produktìv tvarinnictva*. https://www.semanticscholar.org/paper/92acb84676e9f2eb1c1712169f10d394d38a8d59 [3] Choi, M.-Y., Köhler, R., Vander Meer, R. V., Neupert, S., & Predel, R. (2014). Identification and Expression of Capa Gene in the Fire Ant, *Solenopsis invicta*. *PLoS ONE*. https://www.semanticscholar.org/paper/d5b382a74faba00239c4add47dd252b66c763d63 [4] Diesner, M., Bläser, M., Eckardt, S., Iliffe, T., Theile, E. B., & Predel, R. (2021). Expression pattern of CAPA/pyrokinin neuropeptide genes in Remipedia and silverfish: rapid differentiation after gene duplication in early Hexapoda, followed by strong conservation of newly established features in insects. *Peptides*. https://www.semanticscholar.org/paper/053b13963eea052ce38d06bae8edc3585f1f6d96 [5] Correction: Identification and Expression of Capa Gene in the Fire Ant, *Solenopsis invicta*. (2014). *PLoS ONE*. https://www.semanticscholar.org/paper/326e364df3cb47d2d95ea2508c9996c172a0a911 [6] Predel, R., Neupert, S., Russell, W., Hauser, F., Russell, D., Li, A., & Nachman, R. (2013). CAPA-gene products in the haematophagous sandfly *Phlebotomus papatasi* (Scopoli)--vector for leishmaniasis disease. *Peptides*. https://www.semanticscholar.org/paper/ba488e2f7e9f34f6c1548892f93492975edfa659 [7] Mitioglo, I. (2021). Capa-casein gene polymorphism in cows of different breeds of dairy productivity